Contact Us

•treatment options

TEXT SIZE

imwg guidelines    back International Myeloma Working Group (IMWG) Guidelines for Serum Free Light Chain Analysis in Multiple Myeloma and Related Disorders

	07.09.10
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share |  related articles Management of Treatm... Allogeneic Stem Cell... Molecular (Genetic) ... Serum Free Light Cha... Response Criteria Prevention of Blood ... Vertebral Augmentati... Treatment of Older P... Diagnosis and Diagno... Requirements for a M... Imaging Techniques f... Bisphosphonate Thera...

Management of Treatment-Emergent Peripheral Neuropathy
	Strategies for managing PN include early and regular monitoring, dose modification, and treatment discontinuation.

---

Allogeneic Stem Cell Transplant

---

Molecular (Genetic) Classification

---

Serum Free Light Chain Analysis

---

Response Criteria

---

Prevention of Blood Clots (Thromboembolic Events)

---

Vertebral Augmentation

---

Treatment of Older Patients/Ineligible for Transplant

---

Diagnosis and Diagnostic Work-up of Myeloma

---

Requirements for a Myeloma Specialty Center (Facilities and Services)

---

Imaging Techniques for Diagnosis and Monitoring

---

Bisphosphonate Therapy (Zometa and Aredia)

---